RHINOMED TAKES BIG APPLE IN US SLEEP MARKET PUSH

Written on the 9 May 2016

RHINOMED TAKES BIG APPLE IN US SLEEP MARKET PUSH

A MELBOURNE snoring and sleep aid invention will expand its reach in the US after securing a deal under the Walgreens Boots Alliance.

Rhinomed's (ASX:RNO) sleep quality device Mute will be launched in Duane Reade pharmacies across Manhattan this week.

Made from ultra-soft medical grade polymers, Mute is placed inside the nose and helps snorers keep their mouths closed while asleep and breathe easier.

Rhinomed CEO Michael Johnson says the distribution deal is a major coup for the company following three years of development.

Duane Reade is one of the largest pharmacy chains in the US and represented in 25 countries under the US$100 billion Walgreens Boots Alliance.

"Our goal is to change the way the world breathes, with a suite of products that empower individuals and deliver solutions which they embrace," Johnson says.

"We're witnessing a significant emotional response from customers to this product, because they have either snored or had to deal with a snoring partner for many years.

"Many others find breathing through their nose very difficult due to chronic nasal congestion of nasal obstructions caused by deviated septums or broken noses.

"The impact when they first place a Mute into their nose is quite compelling."

Rhinomed has secured a number of international distribution deals for Mute in the past 12 months, including Boots in the UK and Ireland, McArthur Medical in Canada, Europa Sports and sporting stores in the US.

The company is poised to capitalise on a growing industry, with global spending on sleep related products worth more than US$32 billion annually according to IMS Health.

"Compliance is a key industry challenge and the market is crying out for a consumer-focused approach," Johnson says.

"Letting people try the product themselves makes our job easier. The change is instant and utterly recognisable."

Rhinomed plans to boost its foothold in America, as well as explore opportunities in Europe and Asia.

 


Latest News

COCHLEAR R&D INVESTMENT DRIVES NEW PRODUCTS AND BOOSTS PROFIT AND REVENUE

COCHLEAR (ASX: COH) has boosted its 2017 full year net profit by 18 percent to $223.6 million and has forecast furthe...

WESFARMERS BOOKS BUMPER PROFIT BUT SUPERMARKET WAR HITS COLES' BOTTOM LINE

SUPERMARKET giant Coles has posted its biggest slide in earnings since it was acquired by Wesfarmers (ASX: WES) 10 ye...

TREASURY WINES UNCORKS SWEET $269M PROFIT DESPITE INVENTORY WOES

REVEALING the fruits of its past year of labour, Treasury Wine Estates (ASX: TWE) has posted a 55 per cent increas...

TATTS GROUP POSTS PROFIT AND REVENUE DROP ON FEWER JACKPOTS AND BAD WEATHER FOR RACING

TATTS Group (ASX: TTS) has posted a full year net profit loss of 5.7 percent and a revenue decline of 8.4 per cent as...

Related News

WESFARMERS BOOKS BUMPER PROFIT BUT SUPERMARKET WAR HITS COLES' BOTTOM LINE

SUPERMARKET giant Coles has posted its biggest slide in earnings since it was acquired by Wesfarmers (ASX: WES) 10 ye...

ANALYSTS PREDICT WHAT AUSSIE LIVING IS LIKELY TO BECOME IN THE NEXT CENTURY

AS THE Australian population continues to grow, analysts are predicting what the country is likely to look like wi...

SEVEN WEST REPORTS MASSIVE LOSS AND CUTS CEO TIM WORNER'S PAY PACKET BY $450K

SEVEN West Media (ASX: SWM) has posted a full-year loss of $744.3 million and cut CEO Tim Worner's pay packet by ...

HOW MAKING MISTAKES AND PASSION SCORED WEIGHT LOSS PARTNERS A DEAL WITH SHARK TANK'S JANINE ALLIS

THEY partnered up to provide a scientific and targeted approach to dieting, and Kate Save and Geoff Draper cut Sha...

BOOK YOUR FUNCTION SPACE HERE

 

 

 

Contact us

Email News Update Sign Up Contact Details
Subscriptions

PO Box 2087
Brisbane QLD 4001

LoginTell a FriendSign Up to Newsletter